With the American region dominating the market for lyophilised pharmaceutical products, growing demand has contributed to a projected rise in investment to reach $4.80 billion by 2020. SMi’s Lyophilisation & Freeze Drying USA conference comes at the perfect time and place on 29-30 April 2015 to Iselin, New Jersey, USA.
We have worked closely with a leading panel of experts such as Genentech, GSK, MedImmune, Merck, Genzyme, Bristol-Myers Squibb, Genzyme and Novo Nordisk, to create an agenda that will provide unique insight into topics such as lyophilisation and freeze drying developments, QbD, process analytical techniques & strategies (PAT), PLUS MUCH MORE!
KEY SPEAKERS INCLUDE:
- Swapnil Pansare, Associate Scientist – I, Formulation Sciences, MedImmune
- Akhilesh Bhambhani, Principal Scientist, Novel Adjuvants, Formulations & Delivery Technologies, Merck
- Vikram Sadineni, Senior Research Investigator-II, Bristol-Myers Squibb
- Mark Yang, Director, Fill Finish Development, Genzyme
- Sune Andersen, Principal Scientist in Drying Processes and Particle, Technology in CMC, Novo Nordisk A/S
- Graham Magill, Engineer I, Pharmaceutical Processing and Technology Development, Genentech
- Ronald Pate, Lyophilisation Development Scientist, Patheon Pharmaceuticals
REASONS TO JOIN:
- This scientifically sound event will focus on process formulation and optimisation for biologics and vaccines with a key emphasis on the development of lyophilisation and scale up
- All challenges in lyophilisation and freeze drying technology will be considered and case studies will reflect and address the implementation process
- Recieve an up-to-date perspective of the lyophilisation process and the application in formulating solid protein pharmaceuticals. Review the challenges to enhance improvements
- Don’t miss the round table discussion on quality by design and the future of lyophilisation
We have worked closely with a leading panel of experts such as Genentech, GSK, MedImmune, Merck, Genzyme, Bristol-Myers Squibb, Genzyme and Novo Nordisk, to create an agenda that will provide unique insight into topics such as lyophilisation and freeze drying developments, QbD, process analytical techniques & strategies (PAT), PLUS MUCH MORE!
KEY SPEAKERS INCLUDE:
- Swapnil Pansare, Associate Scientist – I, Formulation Sciences, MedImmune
- Akhilesh Bhambhani, Principal Scientist, Novel Adjuvants, Formulations & Delivery Technologies, Merck
- Vikram Sadineni, Senior Research Investigator-II, Bristol-Myers Squibb
- Mark Yang, Director, Fill Finish Development, Genzyme
- Sune Andersen, Principal Scientist in Drying Processes and Particle, Technology in CMC, Novo Nordisk A/S
- Graham Magill, Engineer I, Pharmaceutical Processing and Technology Development, Genentech
- Ronald Pate, Lyophilisation Development Scientist, Patheon Pharmaceuticals
REASONS TO JOIN:
- This scientifically sound event will focus on process formulation and optimisation for biologics and vaccines with a key emphasis on the development of lyophilisation and scale up
- All challenges in lyophilisation and freeze drying technology will be considered and case studies will reflect and address the implementation process
- Recieve an up-to-date perspective of the lyophilisation process and the application in formulating solid protein pharmaceuticals. Review the challenges to enhance improvements
- Don’t miss the round table discussion on quality by design and the future of lyophilisation
